Literature DB >> 19407149

Replication and assembly of human papillomaviruses.

M J Conway1, C Meyers.   

Abstract

Human papillomaviruses (HPVs) are small dsDNA tumor viruses, which are the etiologic agents of most cervical cancers and are associated with a growing percentage of oropharyngeal cancers. The HPV capsid is non-enveloped, having a T=7 icosahedral symmetry formed via the interaction among 72 pentamers of the major capsid protein, L1. The minor capsid protein L2 associates with L1 pentamers, although it is not known if each L1 pentamer contains a single L2 protein. The HPV life cycle strictly adheres to the host cell differentiation program, and as such, native HPV virions are only produced in vivo or in organotypic "raft" culture. Research producing synthetic papillomavirus particles--such as virus-like particles (VLPs), papillomavirus-based gene transfer vectors, known as pseudovirions (PsV), and papillomavirus genome-containing quasivirions (QV)--has bypassed the need for stratifying and differentiating host tissue in viral assembly and has allowed for the rapid analysis of HPV infectivity pathways, transmission, immunogenicity, and viral structure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407149      PMCID: PMC3317948          DOI: 10.1177/0022034509333446

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  127 in total

1.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Maturation of papillomavirus capsids.

Authors:  Christopher B Buck; Cynthia D Thompson; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

Authors:  Maura L Gillison
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

4.  Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation.

Authors:  Dohun Pyeon; Paul F Lambert; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-15       Impact factor: 11.205

5.  The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding.

Authors:  Alyson Fay; William H Yutzy; Richard B S Roden; Junona Moroianu
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.

Authors:  Nicole A Patterson; Jessica L Smith; Michelle A Ozbun
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.

Authors:  Ioannis Bossis; Richard B S Roden; Ratish Gambhira; Rongcun Yang; Mitsuo Tagaya; Peter M Howley; Patricio I Meneses
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

Authors:  Rongcun Yang; Cosette M Wheeler; Xiaojiang Chen; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Diana V Pastrana; Raphael P Viscidi; Richard B S Roden
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins; Anne Schuind; Toufik Zahaf; Bruce Innis; Paulo Naud; Newton S De Carvalho; Cecilia M Roteli-Martins; Julio Teixeira; Mark M Blatter; Abner P Korn; Wim Quint; Gary Dubin
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

Review 10.  The papillomavirus life cycle.

Authors:  John Doorbar
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

View more
  37 in total

1.  HPV infection and p16 expression in carcinomas of the minor salivary glands.

Authors:  Markus Brunner; Oskar Koperek; Fritz Wrba; Boban M Erovic; Gregor Heiduschka; Christian Schoppper; Dietmar Thurnher
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-30       Impact factor: 2.503

2.  Structural basis of oligosaccharide receptor recognition by human papillomavirus.

Authors:  Jhimli Dasgupta; Malgorzata Bienkowska-Haba; Marcos E Ortega; Hetalkumar D Patel; Sabrina Bodevin; Dorothe Spillmann; Brooke Bishop; Martin Sapp; Xiaojiang S Chen
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

3.  Peptidic inhibitors for in vitro pentamer formation of human papillomavirus capsid protein l1.

Authors:  Ding-Yi Fu; Shi Jin; Dong-Dong Zheng; Xiao Zha; Yuqing Wu
Journal:  ACS Med Chem Lett       Date:  2015-02-25       Impact factor: 4.345

4.  Human Papillomavirus Replication Regulation by Acetylation of a Conserved Lysine in the E2 Protein.

Authors:  Yanique Thomas; Elliot J Androphy
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

5.  HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Authors:  Sayuri Miyauchi; P Dominick Sanders; Kripa Guram; Sangwoo S Kim; Francesca Paolini; Aldo Venuti; Ezra E W Cohen; J Silvio Gutkind; Joseph A Califano; Andrew B Sharabi
Journal:  Cancer Res       Date:  2019-12-17       Impact factor: 12.701

6.  Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice.

Authors:  Zahra Kianmehr; Hoorieh Soleimanjahi; Susan Kaboudanian Ardestani; Fatemeh Fotouhi; Asghar Abdoli
Journal:  Med Microbiol Immunol       Date:  2014-09-04       Impact factor: 3.402

7.  Human Papillomavirus infection requires the CCT Chaperonin Complex.

Authors:  Marina Bugnon Valdano; Paola Massimi; Justyna Broniarczyk; David Pim; Michael Myers; Daniela Gardiol; Lawrence Banks
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

8.  Surveying capsid assembly pathways through simulation-based data fitting.

Authors:  Lu Xie; Gregory R Smith; Xian Feng; Russell Schwartz
Journal:  Biophys J       Date:  2012-10-02       Impact factor: 4.033

9.  Epithelial maturation and molecular biology of oral HPV.

Authors:  Liviu Feller; Razia Ag Khammissa; Neil H Wood; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2009-11-25       Impact factor: 2.965

Review 10.  Cellular receptor binding and entry of human papillomavirus.

Authors:  Tan Letian; Zhang Tianyu
Journal:  Virol J       Date:  2010-01-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.